GAM Holding’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

GAM Holding’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-26,955	Closed	-$286K	–	1151
2013 Q3	$286K	Buy	+26,955	New	+$236K	0.01%	891

Other funds holding ANAC

Rho Capital Partners New York $20.4M AUM

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

GAM Holding's ANAC Position: Q4 2013 in Review

GAM Holding sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q4 2013, closing a stake of 26,955 shares — an estimated $286K sold.

GAM Holding first reported a position in ANAC in Q3 2013 and held it in 1 quarter. The position peaked at $286K in Q3 2013. 87 funds tracked by Wall St. Rank hold ANAC as of Q4 2013.

GAM Holding reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q4 2013 after selling out during the quarter.
GAM Holding sold 26,955 ANACOR PHARMACEUTICALS INC COM shares in Q4 2013, an estimated $286K.
GAM Holding first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2013 and held it in 1 quarter.
GAM Holding's ANACOR PHARMACEUTICALS INC COM position peaked at $286K in Q3 2013.
87 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q4 2013.

Based on GAM Holding's 13F filing for Q4 2013, filed 12 Feb 2014.